HIMS & HERS HEALTH INC Receives High Rating from Growth Model

HIMS & HERS HEALTH INC shows strong potential as it secures a 77% rating in a guru fundamental report which highlights solid fundamentals but a concern in sales variance.

Date: 03-01-2025

AI Rating: 6

Analysis of HIMS & HERS HEALTH INC

The report indicates a strong performance for HIMS & HERS HEALTH INC under the P/B Growth Investor model. The stock holds a 77% rating, suggesting solid fundamentals, although it falls short in sales variance and research and development metrics.

This analysis does not provide specific figures for Earnings Per Share (EPS), Revenue Growth, Net Income, Profit Margins, Free Cash Flow, or Return on Equity, but it does detail key fundamental factors related to the stock's investment potential.

HIMS has passed criteria like Book/Market Ratio, Return on Assets, and Cash Flow from Operations to Assets, signaling effective management and asset utilization. However, the failure in Sales Variance and Research and Development raises caution, as these metrics can indicate growth stability and innovation capacity.

Investors may consider the high score (77%) favorably, suggesting that HIMS is being viewed positively in terms of its growth potential, while also noting areas that require improvement, particularly in its sales performance and investment into R&D.

Stocks: HIMS